PEAR
Price:
$0.0292
Market Cap:
$4.09M
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2021-03-31
Stock Exchange
NASDAQ
Ticker
PEAR
According to Pear Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -14.46%. This represents a change of -189.99% compared to the average of 16.07% of the last 4 quarters.
The mean historical ROE of Pear Therapeutics, Inc. over the last ten years is -15.91%. The current -14.46% ROE has changed -9.11% with respect to the historical average. Over the past ten years (40 quarters), PEAR's ROE was at its highest in in the December 2022 quarter at 94.25%. The ROE was at its lowest in in the December 2021 quarter at -101.63%.
Average
-15.91%
Median
-20.60%
Minimum
-77.62%
Maximum
55.17%
Discovering the peaks and valleys of Pear Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 245.89%
Maximum Annual ROE = 55.17%
Minimum Annual Increase = -394.07%
Minimum Annual ROE = -77.62%
Year | ROE | Change |
---|---|---|
2022 | -77.62% | 245.89% |
2021 | -22.44% | -140.67% |
2020 | 55.17% | -394.07% |
The current ROE of Pear Therapeutics, Inc. (PEAR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-14.96%
5-year avg
-15.91%
10-year avg
-15.91%
Pear Therapeutics, Inc.’s ROE is greater than Healthcare Triangle, Inc. (-773.20%), greater than Bullfrog AI Holdings, Inc. Common Stock (-130.79%), less than EUDA Health Holdings Limited (126.41%), greater than Mangoceuticals, Inc. (-228.14%), greater than Minerva Surgical, Inc. (-108.66%), less than FOXO Technologies Inc. (79.52%), greater than ETAO International Co., Ltd. (-145.71%), greater than Science 37 Holdings, Inc. (-170.69%), greater than Aclarion, Inc. (-910.70%), greater than Augmedix, Inc. (-182.36%), greater than Aclarion, Inc. (-910.70%), greater than Akili, Inc. (-74.46%),
Company | ROE | Market cap |
---|---|---|
-773.20% | $3.96M | |
-130.79% | $18.92M | |
126.41% | $104.68M | |
-228.14% | $8.04M | |
-108.66% | $106.54K | |
79.52% | $2.04M | |
-145.71% | $9.78M | |
-170.69% | $34.66M | |
-910.70% | $1.66M | |
-182.36% | $114.18M | |
-910.70% | $1.74M | |
-74.46% | $34.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pear Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pear Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Pear Therapeutics, Inc.'s ROE?
How is the ROE calculated for Pear Therapeutics, Inc. (PEAR)?
What is the highest ROE for Pear Therapeutics, Inc. (PEAR)?
What is the 3-year average ROE for Pear Therapeutics, Inc. (PEAR)?
What is the 5-year average ROE for Pear Therapeutics, Inc. (PEAR)?
How does the current ROE for Pear Therapeutics, Inc. (PEAR) compare to its historical average?